A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(41 sites)

United States

Research Site, Huntsville, Alabama

Research Site, Chula Vista, California

Research Site, Glendale, California

Research Site, Granada Hills, California

Research Site, Los Angeles, California

Research Site, Northridge, California

Research Site, Oxnard, California

Research Site, Riverside, California

Research Site, San Dimas, California

Research Site, Tarzana, California

Research Site, Valencia, California

Research Site, Victorville, California

Research Site, Englewood, Colorado

Research Site, Bradenton, Florida

Research Site, Coral Springs, Florida

Research Site, Hollywood, Florida

Research Site, Orlando, Florida

Research Site, Tampa, Florida

Research Site, Chicago, Illinois

Research Site, Iowa City, Iowa

Research Site, Baltimore, Maryland

Research Site, Detroit, Michigan

Research Site, Pontiac, Michigan

Research Site, Tupelo, Mississippi

Research Site, Kansas City, Missouri

Research Site, Lincoln, Nebraska

Research Site, Jersey City, New Jersey

Research Site, Albuquerque, New Mexico

Research Site, Ridgewood, New York

Research Site, Kinston, North Carolina

Research Site, Winston-Salem, North Carolina

Research Site, Bethlehem, Pennsylvania

Research Site, Knoxville, Tennessee

Research Site, Beaumont, Texas

Research Site, Dallas, Texas

Research Site, Houston, Texas

Research Site, McAllen, Texas

Research Site, San Antonio, Texas